Our Pricing

Wegovy 0.5mg UK Prescription Weight Loss Treatment

Starting your wegovy 0.5mg uk prescription online journey begins with understanding this initial dose phase. At Cured Pharmacy, our UK-registered clinical team provides free online consultations under 3 minutes, with genuine UK-licensed Wegovy available from £79.00 and transparent upfront pricing before you complete your assessment.

What Is Wegovy 0.5mg and How Does It Work?

Wegovy 0.5mg contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. The 0.5mg dose represents the second escalation step in the Wegovy dosing schedule, administered once weekly via subcutaneous injection.

Semaglutide works by mimicking the action of glucagon-like peptide-1, a naturally occurring hormone that regulates appetite and food intake. It slows gastric emptying, increases feelings of fullness, and reduces hunger signals to the brain [1]. In the landmark STEP 1 clinical trial, participants achieved an average 14.9% body weight reduction over 68 weeks when combined with lifestyle interventions [2].

The 0.5mg dose is not a maintenance dose — it's part of a carefully designed escalation protocol that allows your body to adjust gradually, minimising gastrointestinal side effects whilst building therapeutic efficacy. Most patients spend four weeks at this dose before progressing to higher strengths, subject to prescriber approval and individual tolerance.

Wegovy 0.5mg Dosing Schedule and Escalation Protocol

The Wegovy dosing schedule follows a structured five-month escalation designed to optimise tolerability and clinical outcomes. You begin at 0.25mg for four weeks, then progress to 0.5mg for the next four weeks, followed by 1mg, 1.7mg, and finally the maintenance dose of 2.4mg [3].

This gradual titration is evidence-based — clinical trials demonstrated that patients who followed the escalation protocol experienced significantly fewer treatment discontinuations due to gastrointestinal adverse events compared to those who started at higher doses [3]. Your UK prescriber will monitor your progress throughout each dose phase and may adjust the timeline based on your individual response and tolerability.

What to Expect During Your 0.5mg Phase

During your four weeks at 0.5mg, you may notice increased appetite suppression compared to the 0.25mg starter dose. Some patients report mild nausea, particularly in the first few days after dose escalation, though this typically subsides as your body adjusts. Maintaining adequate hydration and eating smaller, more frequent meals can help manage these effects. If side effects become problematic, your prescriber may recommend staying at 0.5mg for an additional month before progressing further.

How to Administer Your Wegovy 0.5mg Injection

Wegovy comes in a pre-filled, single-dose pen designed for ease of use. Each 0.5mg pen is colour-coded for dose identification and contains one week's treatment. You'll inject into the subcutaneous tissue of your abdomen, thigh, or upper arm — rotating injection sites each week helps prevent lipodystrophy and maintains consistent absorption.

The injection process takes less than a minute: remove the pen cap, place the pen against your chosen injection site at a 90-degree angle, press the dose button firmly until you hear a click, and hold for 6 seconds to ensure full dose delivery. No dose preparation or mixing is required. Your Wegovy supply will include detailed patient information leaflets, and our pharmacy team at Cured Pharmacy is available on (+44) 116 4646009 if you need injection technique guidance.

Store unused pens in the refrigerator between 2°C and 8°C. Once you've started using a pen, it can be kept at room temperature (below 30°C) for up to 28 days. Never freeze Wegovy, and always inspect the solution before use — it should be clear and colourless.

Missed Dose Protocol

If you miss your weekly Wegovy dose and it's been less than 5 days, take it as soon as you remember. If more than 5 days have passed, skip that dose entirely and resume your normal schedule with the next planned injection [3]. Never double up doses to compensate for a missed injection, as this significantly increases the risk of gastrointestinal side effects.

Wegovy 0.5mg Price UK and Value Comparison

At Cured Pharmacy, Wegovy is available from £79.00 with transparent upfront pricing displayed before you complete your clinical assessment. This pricing includes your UK prescriber consultation, medication supply, and discreet delivery to your address. Unlike some providers, we never hide costs behind consultation fees or surprise charges at checkout.

As a UK-registered pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we guarantee genuine UK-licensed Wegovy pens sourced through legitimate pharmaceutical supply chains. Every pen carries full MHRA approval and product authentication. Our Lowest Prices Guaranteed commitment means you're getting competitive UK pricing without compromising on medication quality or clinical oversight.

The cost-effectiveness of Wegovy extends beyond the prescription price. Clinical evidence shows that sustained weight loss achieved with semaglutide can reduce healthcare costs associated with obesity-related conditions including type 2 diabetes, cardiovascular disease, and osteoarthritis [4]. Many patients find that the investment in prescription weight management delivers long-term health and economic benefits that far exceed the initial medication cost.

Wegovy 0.5mg Side Effects and Safety Considerations

The most common side effects during the 0.5mg dose phase are gastrointestinal: nausea affects approximately 44% of patients, diarrhoea 30%, vomiting 24%, and constipation 24%, though these percentages represent data across all dose levels in clinical trials [2]. Most gastrointestinal effects are mild to moderate, peak during dose escalation periods, and diminish with continued use.

Serious adverse events are rare but require immediate medical attention. These include signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder problems (upper right abdominal pain, fever, yellowing of skin or eyes), kidney problems (changes in urination, swelling in legs or feet), and allergic reactions (rash, difficulty breathing, rapid heartbeat) [3]. Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans. It should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Before starting Wegovy 0.5mg, your UK prescriber will review your complete medical history, including any history of pancreatitis, diabetic retinopathy, kidney disease, or eating disorders. Wegovy is contraindicated during pregnancy and breastfeeding. Women of childbearing potential should use effective contraception and discontinue Wegovy at least 2 months before a planned pregnancy due to the medication's long washout period [3].

Drug Interactions and Precautions

Wegovy slows gastric emptying, which can affect the absorption of oral medications, particularly those requiring rapid absorption or with narrow therapeutic indices. If you take oral medications for diabetes, thyroid conditions, or contraception, inform your prescriber during your assessment. Patients taking insulin or insulin secretagogues may require dose adjustments to prevent hypoglycaemia. Always disclose your complete medication list, including over-the-counter products and herbal supplements, during your clinical consultation.

Starting Your Wegovy 0.5mg UK Prescription at Cured Pharmacy

Beginning your wegovy 0.5mg uk prescription online at Cured Pharmacy takes under 3 minutes. Our clinical assessment covers your weight history, current health conditions, medications, and weight loss goals. You'll answer questions about contraindications including thyroid history, pancreatitis, and pregnancy status. A UK-registered prescriber reviews every assessment individually — this isn't an automated approval process.

If Wegovy is clinically appropriate for you, your prescription is issued electronically and sent directly to our dispensing pharmacy. We source all Wegovy stock from UK-licensed wholesalers, ensuring full product traceability and cold chain integrity. Your medication ships in temperature-controlled packaging with discreet outer labelling, typically arriving within 1-2 working days via tracked courier.

Your care doesn't end at checkout. Our pharmacy team provides ongoing support throughout your treatment journey, including dose escalation guidance, side effect management, and injection technique troubleshooting. You can reach us at (+44) 116 4646009 during business hours, or message through your account for non-urgent queries. When you're ready to progress from 0.5mg to 1mg after your four-week dose phase, simply complete a brief follow-up assessment and we'll arrange your next supply, subject to prescriber approval.

Who Is Eligible for Wegovy 0.5mg?

Wegovy is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [1]. You must be willing to engage with lifestyle modifications including reduced-calorie diet and increased physical activity, as Wegovy is licensed as an adjunct to these interventions, not a replacement. Your UK prescriber will calculate your BMI during the assessment and determine clinical suitability based on your complete health profile.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4
3. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
4. Kushner, R. F., et al. (2020). Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity, 28(6), 1050–1061. https://doi.org/10.1002/oby.22794

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and suitability is determined on an individual basis following clinical review.